The Carlyle Group, Signet and OrbiMed Partially Exit Claris Lifesciences (Asia)

Private equity firms The Carlyle Group, Signet Healthcare and OrbiMed have partially exited their investment in India-based pharmaceutical company Claris Lifesciences by participating in the company’s buyback offer. Claris Lifesciences offered a buyback issue worth INR2.3 billion (approximately US$39 million) in March 2014. The buyback was offered at a… Read More

GP Investments to Exit Sascar Participações (Latin America)

Latin America-focused alternative investment company GP Investments has agreed to sell its stake in Brazil-based fleet management and cargo tracking services provider Sascar Participações to Compagnie Financiere du Groupe Michelin, a company that holds Groupe Michelin’s industrial and commercial companies outside of France, as part of Groupe Michelin’s acquisition… Read More

CNEI Invests US$10.5 Million in Qinghai Weide Special Sugar (Asia)

China-focused growth capital fund manager China New Enterprise Investment (CNEI) has invested US$10.5 million in China-based Qinghai Weide Special Sugar, a producer of inulin and fructooligosaccharide, two prebiotics and dietary fiber products that are used in baby formula, drinks, food, animal feed, cosmetics and personal care products. CNEI’s investment… Read More



(default archive template)